All terms

    Notified Body

    EU-designated organization that assesses conformity of medical devices under MDR and IVDR.

    Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 5, 2026

    Definition

    A Notified Body is an organization designated by an EU Member State competent authority (and listed in NANDO) to carry out conformity assessment tasks under Regulation (EU) 2017/745 (MDR) or 2017/746 (IVDR) before a device is placed on the EU market. Designation itself is governed by Implementing Regulation (EU) 2017/2185 and the joint assessment process.
    What the regulation says
    Under the EU Medical Device Regulation (MDR 2017/745) and In Vitro Diagnostic Regulation (IVDR 2017/746), Notified Bodies are conformity assessment bodies designated and monitored by national authorities to ensure that MedTech products meet the necessary safety and performance requirements before market placement. Their responsibilities include auditing manufacturers' quality management systems, assessing technical documentation, and issuing CE certificates, as detailed in MDR Annex VII and IVDR Annex VII.

    What this means in practice

    Under MDR/IVDR, Notified Body involvement is required for all devices above Class I (non-sterile, non-measuring, non-reusable surgical) and above IVD Class A non-sterile. As of 2026 there are approximately 50 MDR-designated and 15 IVDR-designated Notified Bodies, versus 80+ under the prior directives, which has driven multi-year queue times. The Commission and MDCG have issued repeated guidance (MDCG 2022-4, MDCG 2022-14, MDCG 2023-3) to increase capacity. Notified Bodies audit the quality management system, review technical documentation, issue CE certificates (valid up to 5 years), and conduct annual surveillance audits including unannounced audits per Implementing Regulation (EU) 2013/920.

    Examples

    • BSI (UK/NL), TUV SUD (DE), TUV Rheinland (DE), DEKRA (DE), DNV (NO), IMQ (IT) are among the most active MDR Notified Bodies.
    • A Class IIb implantable receives Annex IX Chapter II technical documentation assessment on a representative device from each generic device group.
    • Class III and implantables trigger scrutiny procedure (Article 54) and expert panel consultation for certain novel devices.
    Common pitfalls
    • Submitting incomplete technical documentation. Notified Bodies charge for each round of review and clock the review time against contractual SLAs.
    • Assuming a legacy MDD/IVDD Notified Body will automatically be designated for MDR/IVDR. Designation is per-code and per-regulation.
    • Not planning for unannounced audits at critical suppliers. Article 44 of MDR requires the manufacturer to ensure the Notified Body has access.
    • Confusing Notified Body with Competent Authority. Notified Bodies do conformity assessment; Competent Authorities do market surveillance and vigilance oversight.

    Frequently asked questions

    Match your device MDA/MDN/MDS or IVR/IVS/IVT codes to the Notified Body's scope in NANDO. Factor in queue length, language, cost, and prior sector experience (active implantables, IVDs, software) - these vary widely.

    Cross-references

    Used by

    Shared paths + category

    Latest in MedTech

    Primary references

    3 sources
    Link health: 1 verified 2 unchecked· last checked 2026-06-20
    European Commission·1MDCG·1EUR-Lex·1
    1. 1
      NANDO Notified Body database
      Unchecked
      European Commissionec.europa.eu
    2. 2
      MDCG 2022-11 Notified Body transfer
      Unchecked
      MDCGhealth.ec.europa.eu
    3. 3
      Regulation (EU) 2017/745 Chapter IV
      Verified
      EUR-Lexeur-lex.europa.eu

    Inline markers like [1] jump to the matching reference above.